Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

PURPOSE: Several randomized trials investigating the preferable first-line combination chemotherapy regimen for metastatic colorectal cancer have shown inconsistent findings. Because a substantial number of patients are still being treated with “chemo-only” first-line therapies without targeted agen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Epidemiol
Egile Nagusiak: Marschner, Norbert, Arnold, Dirk, Engel, Erik, Hutzschenreuter, Ulrich, Rauh, Jacqueline, Freier, Werner, Hartmann, Holger, Frank, Melanie, Jänicke, Martina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4408959/
https://ncbi.nlm.nih.gov/pubmed/25945067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S73857
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak